Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 22 min ago
Peer-reviewedCC BYBiomedicines

Plasma IgG N-Glycosylation as a Novel Biomarker of Disease Severity and Prognosis in Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

  1. 1Division of Hematology, Clinical Hospital Merkur, 10000 Zagreb, Croatia; (K.M.J.); (M.K.); (I.M.S.); (D.R.-K.)
  2. 2Glycoscience Research Laboratory, Genos Ltd., 10000 Zagreb, Croatia; (M.P.-B.); (F.V.); (I.D.-O.)
  3. 3School of Medicine in Zagreb, University of Zagreb, 10000 Zagreb, Croatia;

Related

  1. Recurrent Hypoglycemia and Hypercalcemia As Presenting Features of CD30-Positive Peripheral T-cell Lymphoma, Not Otherwise Specified
    Alireza Izadian Bidgoli, Alberto Gomez Usatorres, Hellen Ailette Gomez Usatorres +2
    CureusPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  2. Beyond Prognosis: A Systematic Review of the Neutrophil-to-Lymphocyte Ratio as a Modifiable Cardiovascular Biomarker
    Yousof Alemi, Muhammad K Haider, Muhammad S Khan +6
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Reduced serum Dickkopf-1 levels as a potential supportive biomarker for the development and severity of retinopathy of prematurity: a prospective observational clinical study
    Nuriye Emiroğlu, Hasan Çetin, Hüseyin Altunhan +2
    Frontiers in pediatricsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Multidimensional Inflammatory Biomarker Profiling in COPD: A Latent Inflammatory Construct Associated with Disease Severity and Exacerbation Burden
    Oana Maria Catana, Ramona Cioboata, Denisa Maria Mitroi +3
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. LncRNA RASAL2-AS1 serves as a potential biomarker for prognosis and regulates cellular processes via the miR-590-5p/PDCD5 axis and Wnt/β-catenin pathway in cervical cancer
    Ke Yin, Yi Li, Mengying Tang
    HereditasPeer-reviewedCC BY 4.0Full textOncologyPMC
BibTeX
@article{milunovic2026plasma,
  title = {{Plasma IgG N-Glycosylation as a Novel Biomarker of Disease Severity and Prognosis in Diffuse Large B-Cell Lymphoma, Not Otherwise Specified}},
  author = {Vibor Milunović and Maja Pučić-Baković and Frano Vučković and Ivana Duvnjak-Orešković and Karla Mišura Jakobac and Marin Kursar and Inga Mandac Smoljanović and Delfa Radić-Krišto and Slavko Gašparov},
  journal = {Biomedicines},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13701574},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Plasma IgG N-Glycosylation as a Novel Biomarker of Disease Severity and Prognosis in Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
AU  - Vibor Milunović
AU  - Maja Pučić-Baković
AU  - Frano Vučković
AU  - Ivana Duvnjak-Orešković
AU  - Karla Mišura Jakobac
AU  - Marin Kursar
AU  - Inga Mandac Smoljanović
AU  - Delfa Radić-Krišto
AU  - Slavko Gašparov
PY  - 2026
DA  - 2026/09/23
JO  - Biomedicines
UR  - https://europepmc.org/article/PMC/PMC13701574
SN  - 2227-9059
ER  -